跳至主要内容
临床试验/NL-OMON42747
NL-OMON42747已完成不适用

PRostate Evaluation for Clinically Important disease: Sampling using Image-guidance Or Not? - PRECISIO

Radboud Universitair Medisch Centrum0 个研究点目标入组 17 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
17

研究概览

简要总结

Trial is onging in other countries

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Men at least 18 years of age regerred with clinical suspicion of prostate cancer who have been advised to have a prostate biopsy.
  • PSA * 20ng/ml within the previous 3 months
  • Suspected stage * T2 on rectal examination (organ-confined prostate cancer) within the previous 3 months

排除标准

  • Prior prostate biopsy
  • Prior treatment for prostate cancer
  • Contrainidaction to MRI
  • Contraindication to prostate biopsy
  • evidence of untreated urinary tract infection
  • Previous hipreplacement surgery, metallic hip replacement

研究者

相似试验

PRostate Evaluation for Clinically Important... | 临床试验